Ling Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ling Li has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Tong Zhang
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China
7 shared publications - Bing Wang
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
5 shared publications Tong Zhang
4 shared publicationsJing Li
3 shared publications- Tong Zhang
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine (Shanghai University of Traditional Chinese Medicine), Shanghai 201203, China
3 shared publications Nan Wang
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Elsevier in SSRN Electronic Journal
Identification of Q-markers and Optimization of a Standardized Modern Preparation Process for Shaoyao Gancao Decoction Based on an Integrated Quality Evaluation Strategy
Objective: Using Shaoyao Gancao Decoction (SGD) as a model, this study establishes an integrated quality strategy to support Classical Ancient Chinese Formula (CACF) modernization.,Methods: UPLC-Q-TOF-MS/MS identified absorbed prototype compounds; an HPLC fingerprint method was established for chemical characterization. Major components across 15 SGD batches were quantified; grey relational analysis evaluated spectrum-effect relationships with COX-2 inhibition. Q-markers were screened by integrating serum exposure, fingerprint characteristics, detectability, bioactivity, and component variation between herbal pieces and SGD, followed by validation of stability and anti-inflammatory activity. A standardized modern preparation process was developed using dry extract yield and Q-marker transfer rates as optimization indicators, with extraction parameters optimized via response surface methodology. Chemical consistency between the modern preparation of SGD (MP-SGD) and SGD was assessed by HPLC fingerprinting and principal component analysis (PCA).,Results: 15 absorbed prototypes, 25 common fingerprint peaks and 11 major components were identified/quantified. Spectrum-effect analysis and component characteristics identified albiflorin, paeoniflorin, liquiritin, and glycyrrhizic acid as Q-markers. All four exhibited thermal stability within 90 days, COX-2 inhibition, and suppression of LPS-induced NO production in RAW264.7 macrophages. The optimized process gave dry extract yield 20.71% and Q-marker transfer rates of 70.50%, 61.23%, 47.83%, and 39.48%, respectively. The Q-marker-guided process used 8-fold water, 15 min soaking, 50 min extraction, concentration at 75°C to a relative density of 1.10, and spray drying at 80~95°C. PCA showed no separation between MP-SGD and SGD, indicating chemical similarity.,Conclusion: This study established a systematic Q-marker screening strategy and standardized process for MP-SGD, providing a reproducible framework for CACF quality control and modernization.
- 28 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIdentification of Q-markers and Optimization of a Standardized Modern Preparation Process for Shaoyao Gancao Decoction Based on an Integrated Quality Evaluation Strategy
Objective: Using Shaoyao Gancao Decoction (SGD) as a model, this study establishes an integrated quality strategy to support Classical Ancient Chinese Formula (CACF) modernization.,Methods: UPLC-Q-TOF-MS/MS identified absorbed prototype compounds; an HPLC fingerprint method was established for chemical characterization. Major components across 15 SGD batches were quantified; grey relational analysis evaluated spectrum-effect relationships with COX-2 inhibition. Q-markers were screened by integrating serum exposure, fingerprint characteristics, detectability, bioactivity, and component variation between herbal pieces and SGD, followed by validation of stability and anti-inflammatory activity. A standardized modern preparation process was developed using dry extract yield and Q-marker transfer rates as optimization indicators, with extraction parameters optimized via response surface methodology. Chemical consistency between the modern preparation of SGD (MP-SGD) and SGD was assessed by HPLC fingerprinting and principal component analysis (PCA).,Results: 15 absorbed prototypes, 25 common fingerprint peaks and 11 major components were identified/quantified. Spectrum-effect analysis and component characteristics identified albiflorin, paeoniflorin, liquiritin, and glycyrrhizic acid as Q-markers. All four exhibited thermal stability within 90 days, COX-2 inhibition, and suppression of LPS-induced NO production in RAW264.7 macrophages. The optimized process gave dry extract yield 20.71% and Q-marker transfer rates of 70.50%, 61.23%, 47.83%, and 39.48%, respectively. The Q-marker-guided process used 8-fold water, 15 min soaking, 50 min extraction, concentration at 75°C to a relative density of 1.10, and spray drying at 80~95°C. PCA showed no separation between MP-SGD and SGD, indicating chemical similarity.,Conclusion: This study established a systematic Q-marker screening strategy and standardized process for MP-SGD, providing a reproducible framework for CACF quality control and modernization.
- Open Access
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
A chemometric framework for tracking quality value transmission in herbal volatile oil processing: From raw material to cyclodextrin inclusion complex
Objective: To develop a quality value transmission framework for volatile oil preparations based on the β-cyclodextrin inclusion (IC) of Atractylodes macrocephala Koidz. volatile oil (AO). Methods: The IC were prepared via a self-emulsifying strategy guided by molecular simulation. TLC, HPLC fingerprints and contents of 5 components were performed on 15 batches of herb, AO, and IC. A quality value transmission framework was established mainly using Crystal Ball simulation and bootstrap resampling, which virtually amplify the 15-batch preparation data using only Microsoft Excel calculations. Results: Atractylone (ATR) dominated the IC formation through van der Waal forces and self-emulsifying strategy. The chemical profiles from conventional analysis showed that ATR, β-caryophellene jointly indicate sample freshness and high quality of samples, whereas atractylenolides should be limited across herb-AO-IC process. Spearman correlation confirmed the rationality of conventional analysis and clarified the setting of Q-markers based on chemical distribution between and within samples. Crystal ball and Boostrap resampling further demonstrated that the key component ATR should exceed 560, 240 mg/g in AO, IC, respectively, to ensure the stability of process. Conclusion: The proposed multivariate quality value transmission method support Quality-by-Design concept and rational quality control for drug development of complex.
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA chemometric framework for tracking quality value transmission in herbal volatile oil processing: From raw material to cyclodextrin inclusion complex
Objective: To develop a quality value transmission framework for volatile oil preparations based on the β-cyclodextrin inclusion (IC) of Atractylodes macrocephala Koidz. volatile oil (AO). Methods: The IC were prepared via a self-emulsifying strategy guided by molecular simulation. TLC, HPLC fingerprints and contents of 5 components were performed on 15 batches of herb, AO, and IC. A quality value transmission framework was established mainly using Crystal Ball simulation and bootstrap resampling, which virtually amplify the 15-batch preparation data using only Microsoft Excel calculations. Results: Atractylone (ATR) dominated the IC formation through van der Waal forces and self-emulsifying strategy. The chemical profiles from conventional analysis showed that ATR, β-caryophellene jointly indicate sample freshness and high quality of samples, whereas atractylenolides should be limited across herb-AO-IC process. Spearman correlation confirmed the rationality of conventional analysis and clarified the setting of Q-markers based on chemical distribution between and within samples. Crystal ball and Boostrap resampling further demonstrated that the key component ATR should exceed 560, 240 mg/g in AO, IC, respectively, to ensure the stability of process. Conclusion: The proposed multivariate quality value transmission method support Quality-by-Design concept and rational quality control for drug development of complex.
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-23
Chinese Herbal Medicine in Ulcerative Colitis-Associated Carcinogenesis Treatment: Mechanisms, Progress, and Future Directions
Colitis-associated colorectal cancer (CAC) is a highly prevalent malignancy of the digestive tract. The close association between ulcerative colitis (UC) and CAC makes inhibiting this carcinogenic transformation a critical preventive goal. Based on traditional Chinese medicine (TCM) theories of “dampness-heat stasis” and “latent pathogen-induced deficiency”, this review systematically explores the pathological process of ulcerative colitis associated carcinogenesis (UCAC) and its interpretation in TCM. We conducted a comprehensive literature search in CNKI and PubMed databases (2020– 2025), systematically analyzing about 79 relevant studies to summarize the clinical applications of TCM in preventing and treating UCAC progression, including oral and topical herbal therapies, as well as non-pharmacological interventions such as acupuncture. Furthermore, we elucidate the underlying mechanisms of TCM interventions in UCAC, with a focus on gut microbiota modulation and key inflammatory signaling pathways (eg, NF-κB, IL-6/JAK2/STAT3), offering new translational perspectives. The novelty of this review is twofold: firstly, it provides the first systematic synthesis of research progress on therapeutic methods, encompassing oral and topical herbal formulations as well as acupuncture, and molecular mechanisms of TCM for UCAC. Secondly, it advances the field by analyzing TCM theories through the lens of modern medicine, comparing TCM’s holistic approach with Western medicine’s targeted paradigm, and proposing an integrated “gut microbiota-metabolite-target” research framework. This framework aims to furnish a theoretical foundation for both the modernization of TCM and the development of combined therapeutic strategies that leverage the strengths of both medical systems.
- 1 February 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-23
Open AccessChinese Herbal Medicine in Ulcerative Colitis-Associated Carcinogenesis Treatment: Mechanisms, Progress, and Future Directions
Colitis-associated colorectal cancer (CAC) is a highly prevalent malignancy of the digestive tract. The close association between ulcerative colitis (UC) and CAC makes inhibiting this carcinogenic transformation a critical preventive goal. Based on traditional Chinese medicine (TCM) theories of “dampness-heat stasis” and “latent pathogen-induced deficiency”, this review systematically explores the pathological process of ulcerative colitis associated carcinogenesis (UCAC) and its interpretation in TCM. We conducted a comprehensive literature search in CNKI and PubMed databases (2020– 2025), systematically analyzing about 79 relevant studies to summarize the clinical applications of TCM in preventing and treating UCAC progression, including oral and topical herbal therapies, as well as non-pharmacological interventions such as acupuncture. Furthermore, we elucidate the underlying mechanisms of TCM interventions in UCAC, with a focus on gut microbiota modulation and key inflammatory signaling pathways (eg, NF-κB, IL-6/JAK2/STAT3), offering new translational perspectives. The novelty of this review is twofold: firstly, it provides the first systematic synthesis of research progress on therapeutic methods, encompassing oral and topical herbal formulations as well as acupuncture, and molecular mechanisms of TCM for UCAC. Secondly, it advances the field by analyzing TCM theories through the lens of modern medicine, comparing TCM’s holistic approach with Western medicine’s targeted paradigm, and proposing an integrated “gut microbiota-metabolite-target” research framework. This framework aims to furnish a theoretical foundation for both the modernization of TCM and the development of combined therapeutic strategies that leverage the strengths of both medical systems.
- 20 August 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 77 (12) , 1676-1689
Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids
Objectives: Ling Gui Zhu Gan (LGZG) Granules is a marketed traditional Chinese medicine compound granule, which is formulated to be consistent with the key quality attributes of the traditional LGZG Decoction. The volatile components are important parts of its preparation process. Methods: A high-fat diet (HFD)-induced Non-alcoholic fatty liver disease (NAFLD) mouse model was established to evaluate the therapeutic effects of LGZG and preparation of LGZG’s volatile components (IC-LGZG). Gut microbiota composition, Short-chain Fatty Acids (SCFA) levels, and intestinal parameters were assessed, and its correlations were analyzed. Lipopolysaccharide-induced RAW264.7 cells tested anti-inflammatory effects. Key findings: LGZG and IC-LGZG significantly reduced HFD-induced body weight gain, improved lipid profiles and liver function, restored gut microbiota balance, increased beneficial bacteria (Akkermansia, Bacteroides, Parabacteroides, Dubosiella, and Bifidobacterium) that produce SCFAs, thereby enhancing SCFA concentrations (acetic acid, propionic acid, and butyric acid), decreased harmful bacteria abundance, and strengthened the intestinal barrier. In vitro studies showed that LGZG, IC-LGZG, and cinnamaldehyde exerted anti-inflammatory effects. Conclusion: LGZG and its volatile components effectively alleviate the progression of NAFLD by modulating the gut microbiota homeostasis and SCFA levels, and can exert anti-inflammatory effects.
- 20 August 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 77 (12) , 1676-1689
Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids
Objectives: Ling Gui Zhu Gan (LGZG) Granules is a marketed traditional Chinese medicine compound granule, which is formulated to be consistent with the key quality attributes of the traditional LGZG Decoction. The volatile components are important parts of its preparation process. Methods: A high-fat diet (HFD)-induced Non-alcoholic fatty liver disease (NAFLD) mouse model was established to evaluate the therapeutic effects of LGZG and preparation of LGZG’s volatile components (IC-LGZG). Gut microbiota composition, Short-chain Fatty Acids (SCFA) levels, and intestinal parameters were assessed, and its correlations were analyzed. Lipopolysaccharide-induced RAW264.7 cells tested anti-inflammatory effects. Key findings: LGZG and IC-LGZG significantly reduced HFD-induced body weight gain, improved lipid profiles and liver function, restored gut microbiota balance, increased beneficial bacteria (Akkermansia, Bacteroides, Parabacteroides, Dubosiella, and Bifidobacterium) that produce SCFAs, thereby enhancing SCFA concentrations (acetic acid, propionic acid, and butyric acid), decreased harmful bacteria abundance, and strengthened the intestinal barrier. In vitro studies showed that LGZG, IC-LGZG, and cinnamaldehyde exerted anti-inflammatory effects. Conclusion: LGZG and its volatile components effectively alleviate the progression of NAFLD by modulating the gut microbiota homeostasis and SCFA levels, and can exert anti-inflammatory effects.
- 10 December 2024
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 23 (1) , 1-11
Mechanisms of acupuncture at Zusanli (ST36) and its combinational acupoints for stress gastric ulcer based on the correlation between Zang-fu and acupoints
- 10 December 2024
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 23 (1) , 1-11
Mechanisms of acupuncture at Zusanli (ST36) and its combinational acupoints for stress gastric ulcer based on the correlation between Zang-fu and acupoints
- Open Access
- 1 December 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (12) , 101833
A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect
This study aims to preserve the volatile components of Linggui Zhugan (LGZG) decoction, offering an experimental foundation for subsequent preparations efforts. Two modern sample preparation processes were compared with the traditional method approach using HPLC fingerprints. After identifying the main volatile components in LGZG aqueous decoction, the inclusion method of inclusion compounds (IC-LGZG) was established and optimized at laboratory, pilot and production scales. Characterization, stability testing of IC-LGZG, and experiments on gastric ulcer rats were conducted to validate the transferability of chemical composition and pharmaceutical efficacy. The study focused on preserving the volatile components in LGZG modern preparations. HPLC analysis revealed cinnamaldehyde (CA) as the main volatile component in LGZG decoction. The optimized IC-LGZG preparation involved heating aromatic water to 40 °C, adding 20 g/L of β-Cyclodextrin (β-CD), keeping warm and stirring at 300 r for 30 min. This process exhibited good repeatability across different verification tests at varying scales. IC-LGZG obtained effectively transferred CA molecules into the β-CD molecules via encapsulation, remaining stable when stored in sealed and dark conditions. Finally, CA, IC-LGZG and M−LGZG (a mixture of IC-LGZG and water-soluble extract powder) effectively prevented the formation of gastric ulcer by mitigating reductions in IL-10, SOD and the increase of TNF-α, NO, MDA in serum. The IC-LGZG prepared using this process successfully transfers volatile components, both chemically and pharmacologically, making it suitable for modern preparations of LGZG.
- 1 December 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (12) , 101833
Open AccessA preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect
This study aims to preserve the volatile components of Linggui Zhugan (LGZG) decoction, offering an experimental foundation for subsequent preparations efforts. Two modern sample preparation processes were compared with the traditional method approach using HPLC fingerprints. After identifying the main volatile components in LGZG aqueous decoction, the inclusion method of inclusion compounds (IC-LGZG) was established and optimized at laboratory, pilot and production scales. Characterization, stability testing of IC-LGZG, and experiments on gastric ulcer rats were conducted to validate the transferability of chemical composition and pharmaceutical efficacy. The study focused on preserving the volatile components in LGZG modern preparations. HPLC analysis revealed cinnamaldehyde (CA) as the main volatile component in LGZG decoction. The optimized IC-LGZG preparation involved heating aromatic water to 40 °C, adding 20 g/L of β-Cyclodextrin (β-CD), keeping warm and stirring at 300 r for 30 min. This process exhibited good repeatability across different verification tests at varying scales. IC-LGZG obtained effectively transferred CA molecules into the β-CD molecules via encapsulation, remaining stable when stored in sealed and dark conditions. Finally, CA, IC-LGZG and M−LGZG (a mixture of IC-LGZG and water-soluble extract powder) effectively prevented the formation of gastric ulcer by mitigating reductions in IL-10, SOD and the increase of TNF-α, NO, MDA in serum. The IC-LGZG prepared using this process successfully transfers volatile components, both chemically and pharmacologically, making it suitable for modern preparations of LGZG.
- Open Access
Atractylone in the Atractylodes macrocephala Rhizoma Essential Oil and Its Anti-Inflammatory Activity
The aim of this study was to conduct a screening of potential therapeutic compounds found in the Atractylodes macrocephala rhizoma essential oil (AO) and explore its mechanism of action in the treatment of ulcerative colitis (UC). An inflammation cell model was employed in conjunction with phospho-antibody array technology to explore potential therapeutic compounds of AO and their anti-inflammatory and antioxidant effects. Furthermore, we assessed their efficacy and mechanisms of action in treating dextran sulfate sodium (DSS)-induced colitis in mice. Via the screening process, we identified atractylone (ATR) as the primary active compound in AO. It has been demonstrated that ATR can both decrease the levels of tumor necrosis factor (TNF)-α and reactive oxygen species (ROS) and increase the expression of adhesion proteins such as claudin, ZO-1, and occludin in vitro. Moreover, ATR has been shown to improve UC symptoms in vivo. Via a non-targeted metabolomics analysis of colon tissue, we identified 57 distinct metabolites that responded to ATR treatment. Subsequent analysis of the metabolic pathways revealed that the action of ATR was primarily focused on the amino acid metabolism pathway. In summary, ATR may alleviate the symptoms of UC by regulating multiple signaling pathways. Additionally, ATR has a comprehensive function in anti-inflammation, antioxidative stress, and intestinal injury reduction.
Open AccessAtractylone in the Atractylodes macrocephala Rhizoma Essential Oil and Its Anti-Inflammatory Activity
The aim of this study was to conduct a screening of potential therapeutic compounds found in the Atractylodes macrocephala rhizoma essential oil (AO) and explore its mechanism of action in the treatment of ulcerative colitis (UC). An inflammation cell model was employed in conjunction with phospho-antibody array technology to explore potential therapeutic compounds of AO and their anti-inflammatory and antioxidant effects. Furthermore, we assessed their efficacy and mechanisms of action in treating dextran sulfate sodium (DSS)-induced colitis in mice. Via the screening process, we identified atractylone (ATR) as the primary active compound in AO. It has been demonstrated that ATR can both decrease the levels of tumor necrosis factor (TNF)-α and reactive oxygen species (ROS) and increase the expression of adhesion proteins such as claudin, ZO-1, and occludin in vitro. Moreover, ATR has been shown to improve UC symptoms in vivo. Via a non-targeted metabolomics analysis of colon tissue, we identified 57 distinct metabolites that responded to ATR treatment. Subsequent analysis of the metabolic pathways revealed that the action of ATR was primarily focused on the amino acid metabolism pathway. In summary, ATR may alleviate the symptoms of UC by regulating multiple signaling pathways. Additionally, ATR has a comprehensive function in anti-inflammation, antioxidative stress, and intestinal injury reduction.
- Open Access
Stabilization of Essential Oil: Polysaccharide-Based Drug Delivery System with Plant-like Structure Based on Biomimetic Concept
Essential oils (EOs) have stability problems, including volatility, oxidation, photosensitivity, heat sensitivity, humidity sensitivity, pH sensitivity, and ion sensitivity. A drug delivery system is an effective way to stabilize EOs, especially due to the protective effect of polymeric drug carriers. Polysaccharides are frequently employed as drug carrier materials because they are highly safe, come in a variety of forms, and have plentiful sources. Interestingly, the EO drug delivery system is based on the biomimetic concept since it corresponds to the structure of plant tissue. In this paper, we associate the biomimetic plant-like structures of the EO drug delivery system with the natural forms of EO in plant tissues, and summarize the characteristics of polysaccharide-based drug carriers for EO protection. Thus, we highlight the research progress on polysaccharides and their modified materials, including gum arabic, starch, cellulose, chitosan, sodium alginate, pectin, and pullulan, and their use as biomimetic drug carriers for EO preparations due to their abilities and potential for EO protection.
Open AccessStabilization of Essential Oil: Polysaccharide-Based Drug Delivery System with Plant-like Structure Based on Biomimetic Concept
Essential oils (EOs) have stability problems, including volatility, oxidation, photosensitivity, heat sensitivity, humidity sensitivity, pH sensitivity, and ion sensitivity. A drug delivery system is an effective way to stabilize EOs, especially due to the protective effect of polymeric drug carriers. Polysaccharides are frequently employed as drug carrier materials because they are highly safe, come in a variety of forms, and have plentiful sources. Interestingly, the EO drug delivery system is based on the biomimetic concept since it corresponds to the structure of plant tissue. In this paper, we associate the biomimetic plant-like structures of the EO drug delivery system with the natural forms of EO in plant tissues, and summarize the characteristics of polysaccharide-based drug carriers for EO protection. Thus, we highlight the research progress on polysaccharides and their modified materials, including gum arabic, starch, cellulose, chitosan, sodium alginate, pectin, and pullulan, and their use as biomimetic drug carriers for EO preparations due to their abilities and potential for EO protection.